Ad
CLRB Short Information Cellectar Biosciences Inc.
home / stock / clrb / clrb short
Short Information | Cellectar Biosciences Inc. (NASDAQ:CLRB)
| Twenty Trading Day Totals | |
|---|---|
| Total Shorted Volume | 12,321,195 |
| Total Actual Volume | 60,650,010 |
| Short Trends | |
|---|---|
| Cover Days | 16 |
| Short Days | 0 |
| No Change Days | 4 |
| Averages | |
|---|---|
| Average Short Volume | 616,060 |
| Average Short Percentage | 24.68% |
Is there a CLRB Short Squeeze or Breakout about to happen?
See the CLRB Short Analysis for free Sign up or Login
Powered by Squeeze Report
CLRB Twenty Trading Day's Volume to Short Volume Chart
CLRB Twenty Trading Day Price Chart
CLRB Short Data Results Days
| Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
|---|---|---|---|---|---|---|---|
| 01-22-2025 | $0.2506 | $0.247 | $0.259 | $0.245 | 892,736 | 196,071 | 21.96% |
| 01-21-2025 | $0.2463 | $0.2485 | $0.2499 | $0.234 | 1,402,163 | 219,605 | 15.66% |
| 01-17-2025 | $0.248 | $0.2435 | $0.252 | $0.235 | 960,365 | 225,089 | 23.44% |
| 01-16-2025 | $0.25 | $0.2422 | $0.2525 | $0.232 | 2,269,832 | 455,954 | 20.09% |
| 01-15-2025 | $0.255 | $0.2481 | $0.2666 | $0.22975 | 3,551,247 | 635,455 | 17.89% |
| 01-14-2025 | $0.276 | $0.275 | $0.2895 | $0.2536 | 2,042,308 | 411,408 | 20.14% |
| 01-13-2025 | $0.2912 | $0.2818 | $0.309 | $0.266 | 21,179,518 | 1,676,499 | 7.92% |
| 01-10-2025 | $0.31 | $0.2823 | $0.3108 | $0.2707 | 1,632,712 | 207,998 | 12.74% |
| 01-08-2025 | $0.331 | $0.311 | $0.332 | $0.291 | 1,523,397 | 386,732 | 25.39% |
| 01-07-2025 | $0.35 | $0.3419 | $0.3597 | $0.3355 | 577,952 | 129,406 | 22.39% |
| 01-06-2025 | $0.3495 | $0.3499 | $0.3628 | $0.3316 | 1,752,809 | 574,000 | 32.75% |
| 01-03-2025 | $0.32 | $0.3454 | $0.35 | $0.312 | 1,632,196 | 586,488 | 35.93% |
| 01-02-2025 | $0.3137 | $0.3249 | $0.3279 | $0.3 | 1,502,149 | 344,135 | 22.91% |
| 12-31-2024 | $0.29 | $0.299 | $0.299 | $0.28 | 1,470,824 | 475,796 | 32.35% |
| 12-30-2024 | $0.3094 | $0.292 | $0.3169 | $0.2731 | 2,249,174 | 454,206 | 20.19% |
| 12-27-2024 | $0.3071 | $0.3088 | $0.3298 | $0.29 | 2,655,498 | 576,292 | 21.7% |
| 12-26-2024 | $0.27 | $0.3068 | $0.3095 | $0.2512 | 6,231,647 | 2,269,147 | 36.41% |
| 12-24-2024 | $0.27 | $0.2535 | $0.2752 | $0.252 | 800,426 | 262,907 | 32.85% |
| 12-23-2024 | $0.24 | $0.2757 | $0.2793 | $0.24 | 4,129,443 | 1,449,706 | 35.11% |
| 12-20-2024 | $0.24 | $0.235 | $0.2495 | $0.23 | 2,193,614 | 784,301 | 35.75% |
News, Short Squeeze, Breakout and More Instantly...
Cellectar Biosciences Inc. Company Name:
CLRB Stock Symbol:
NASDAQ Market:
Cellectar Biosciences Inc. Website:
Ad
-
Oral Presentation Presented at ASH 2024 Showed Iopofosine I 131 Achieved an 83.6% ORR and Exceeded Primary and Secondary Efficacy Endpoints in Phase 2 CLOVER-WaM Study for Relapsed/Refractory Waldenstrom’s Macroglobulinemia Plans to Advance Iopofosine I 131 Internally, Through Stra...
-
Evaluating strategic options for iopofosine I 131 a late-stage clinical program with compelling Phase 2 data and a substantial market opportunity Focusing on advancing radiotherapeutic assets including alpha- and Auger-emitting radioconjugates into Phase 1 solid tumor studies FLORHA...
-
Phase 2 CLOVER-WaM pivotal study data selected for oral presentation at 66 th Annual American Society of Hematology Meeting and Exposition Raised approximately $19.4 million with potential to raise up to an additional $73.3 million Company to hold webcast and conferenc...